Live Breaking News & Updates on Topical Clascoterone Cream

Stay updated with breaking news from Topical clascoterone cream. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ascletis Announces ASC40, a First-in-Class, Once-Daily Oral FASN Inhibitor, Achieved Endpoints in Phase II Clinical Trial for Acne

Ascletis Announces ASC40, a First-in-Class, Once-Daily Oral FASN Inhibitor, Achieved Endpoints in Phase II Clinical Trial for Acne
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , Leihong Xiang , Ann Pharmacother , Jinzij Wu , Fudan University , Hong Kong Stock Exchange , Drug Administration , Physician Of Dermatological Department , Dermatology Division Of Chinese Medical Doctor Association , Institute Of Dermatology , Ascletis Pharma Inc , Ascletis Pharma , Study Results , Topical Clascoterone Cream , Facial Acne , Two Phase , Clinical Trials , Chief Physician , Dermatological Department , Huashan Hospital , Executive Deputy Director , Deputy Director , Dermatology Division , Chinese Medical Doctor Association , Novel Androgen Receptor Inhibitor Fits Into , Acne Treatment ,

Ascletis Announces Completion of 180 Patient Enrollment for Phase II Clinical Trial of FASN Inhibitor ASC40 for Acne

To date, approximately 50% enrolled patients have completed 12-week treatment and all enrolled patients are expected to complete 12-week treatment by the end. ....

United States , Hong Kong , Leihong Xiang , Jinzij Wu , Physician Of Dermatological Department , Fudan University , Hong Kong Stock Exchange , Institute Of Dermatology , Drug Administration , Dermatology Division Of Chinese Medical Doctor Association , Ascletis Pharma Inc , Ascletis Pharma , Global Assessment , Chief Physician , Dermatological Department , Huashan Hospital , Executive Deputy Director , Deputy Director , Dermatology Division , Chinese Medical Doctor Association , Topical Clascoterone Cream , Patients With Facial Acne , Two Phase , North America , Ascletis Pharma Inc ,